Roowin

Roowin is a specialized chemistry-focused CRO that accelerates the development of small molecule therapeutics from discovery to early clinical phases. Leveraging deep expertise in complex process chemistry and analytical development, the company offers a critical outsourcing solution for biotechs and pharma companies needing to advance candidates toward IND/IMPD submissions. Its value proposition is built on a highly educated scientific team, a track record of advancing over a hundred molecules to the clinic, and recent regulatory approval from the French ANSM for its GMP operations. Roowin operates as a service provider, generating revenue through contracted research and manufacturing work.

Integrated chemistry and analytical services platform for small molecule drug development, including custom synthesis, process chemistry, scale-up, cGMP manufacturing, and analytical method development. Leverages a highly educated team with deep expertise in complex fine chemistry.

Roowin competes in the fragmented global market for chemistry-focused CROs and CDMOs. It differentiates itself through a specialized focus on complex fine chemistry, a high-touch, agile service model for early-stage projects, and a strong scientific team. Its competition ranges from large, full-service CDMOs (e.g., Lonza, Catalent) to smaller regional chemistry service providers across Europe and Asia.